Literature DB >> 10533287

Fumarate metabolism and the microaerophily of Campylobacter species.

M A Smith1, G L Mendz, M A Jorgensen, S L Hazell.   

Abstract

(1) The role of fumarate metabolism in the microaerophily of the Campylobacter genus and the effects of therapeutic agents against it were investigated. (2) NMR spectroscopy was employed to determine the properties of Campylobacter fumarase (Fum) and fumarate reductase (Frd). Radiotracer analysis was used to determine the production of carbon dioxide by Campylobacter cells. Standard microbiological techniques were used to measure the effects of environmental conditions and inhibitors on bacterial growth. (3) All Campylobacter species tested showed both Fum and Frd activities. Frd activity was observed with or without the addition of an exogenous electron donor in the particulate fractions obtained from lysates. Fumarate was oxidized to carbon dioxide via the acetyl-CoA cleavage pathway. The genes encoding proteins involved in fumarate metabolism were identified in the Campylobacter jejuni genome. Cells grew better in atmospheres with 5 and 10% oxygen levels. Fum activity was the same in cultures grown under different oxygen tensions and did not vary with the age of cultures. Frd activity was higher in cultures which grew at faster rates and decreased with the age of cultures. Four Frd inhibitors showed bactericidal effects against Campylobacter spp. with different potencies. The relative strengths of inhibition of the compounds followed the same order as the bactericidal effects. (4) The results suggested that Frd and Fum are constitutive and play a fundamental role in these microaerophiles which show characteristics of anaerobic metabolism, and that the Frd inhibitors tested would not be of therapeutic use.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10533287     DOI: 10.1016/s1357-2725(99)00062-x

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  13 in total

1.  Heterologous production in Wolinella succinogenes and characterization of the quinol:fumarate reductase enzymes from Helicobacter pylori and Campylobacter jejuni.

Authors:  Mauro Mileni; Fraser MacMillan; Christos Tziatzios; Klaus Zwicker; Alexander H Haas; Werner Mäntele; Jörg Simon; C Roy D Lancaster
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

2.  A novel testosterone catabolic pathway in bacteria.

Authors:  Yann-Lii Leu; Po-Hsiang Wang; Ming-Shi Shiao; Wael Ismail; Yin-Ru Chiang
Journal:  J Bacteriol       Date:  2011-07-01       Impact factor: 3.490

3.  Campylobacter jejuni gene expression in the chick cecum: evidence for adaptation to a low-oxygen environment.

Authors:  C A Woodall; M A Jones; P A Barrow; J Hinds; G L Marsden; D J Kelly; N Dorrell; B W Wren; D J Maskell
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 4.  Change is good: variations in common biological mechanisms in the epsilonproteobacterial genera Campylobacter and Helicobacter.

Authors:  Jeremy J Gilbreath; William L Cody; D Scott Merrell; David R Hendrixson
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

5.  Identification of Campylobacter jejuni genes involved in its interaction with epithelial cells.

Authors:  Veronica Novik; Dirk Hofreuter; Jorge E Galán
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

6.  Unique features of a highly pathogenic Campylobacter jejuni strain.

Authors:  Dirk Hofreuter; Jennifer Tsai; Robert O Watson; Veronica Novik; Bill Altman; Michelle Benitez; Christina Clark; Clotilde Perbost; Thomas Jarvie; Lei Du; Jorge E Galán
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

7.  Growth of Campylobacter jejuni supported by respiration of fumarate, nitrate, nitrite, trimethylamine-N-oxide, or dimethyl sulfoxide requires oxygen.

Authors:  Michael J Sellars; Stephen J Hall; David J Kelly
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

8.  The genome-sequenced variant of Campylobacter jejuni NCTC 11168 and the original clonal clinical isolate differ markedly in colonization, gene expression, and virulence-associated phenotypes.

Authors:  Erin C Gaynor; Shaun Cawthraw; Georgina Manning; Joanna K MacKichan; Stanley Falkow; Diane G Newell
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

9.  Oxantel disrupts polymicrobial biofilm development of periodontal pathogens.

Authors:  Stuart Dashper; Neil O'Brien-Simpson; Sze Wei Liu; Rita Paolini; Helen Mitchell; Katrina Walsh; Tanya D'Cruze; Brigitte Hoffmann; Deanne Catmull; Ying Zhu; Eric Reynolds
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

10.  The dual-functioning fumarate reductase is the sole succinate:quinone reductase in Campylobacter jejuni and is required for full host colonization.

Authors:  Rebecca A Weingarten; Michael E Taveirne; Jonathan W Olson
Journal:  J Bacteriol       Date:  2009-06-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.